By Rhea Healy2016-07-05T15:48:00+01:00
Bedfont® Scientific Limited, a medical device manufacturer, has passed its latest US Food and Drug Administration (FDA) inspection with flying colours.
Following an inspection of its premises in Kent, UK, the breath analysis specialist was found to be fully compliant with Good Manufacturing Practice (GMP) – meaning its products are manufactured to the highest possible quality.
Louise Bateman, QA & RA Manager, stated, “With this outcome, it shows we are working as a compliant company to FDA standards and are able to continue to provide high-quality products to the US.”
General Manager Jason Smith added, “Bedfont’s aim for the future with this clean bill of health is to continue with our scientific contributions to health, including research and development into new medical breath analysis applicators, to help save lives, one breath at a time.”
Bedfont specialises in the manufacture of exhaled breath and gas monitoring instruments for worldwide medical, scientific and industrial sectors. 2016 marks 40 years in business for the UK-based corporation.
Following the success of its NOxBOX+ and NOxBOXO2 monitors for INO therapy, Bedfont Scientific has now designed and built the NOxBOXi intelligent INO delivery and monitoring system.
Month on month, the gasworld website is the market-leading news portal for the global industrial gas sector, growing at an unprecedented rate and keeping its readers at the forefront of breaking news, insightful analysis and must-see features across the industry. Launched in 2004 and continually evolving, it is the only independent online news, views and intelligence portal for the global industrial gas community and the larger end-user markets – and home to the ever-increasing range of gasworld platforms.
To find out more about gasworld's advertising opportunities click here.